Cargando…
Successful use of methylprednisolone for treating severe COVID-19
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256545/ https://www.ncbi.nlm.nih.gov/pubmed/32479759 http://dx.doi.org/10.1016/j.jaci.2020.05.021 |
_version_ | 1783539933526360064 |
---|---|
author | Liu, Jing Zheng, Xiaobin Huang, Yiying Shan, Hong Huang, Jin |
author_facet | Liu, Jing Zheng, Xiaobin Huang, Yiying Shan, Hong Huang, Jin |
author_sort | Liu, Jing |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7256545 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American Academy of Allergy, Asthma & Immunology |
record_format | MEDLINE/PubMed |
spelling | pubmed-72565452020-05-29 Successful use of methylprednisolone for treating severe COVID-19 Liu, Jing Zheng, Xiaobin Huang, Yiying Shan, Hong Huang, Jin J Allergy Clin Immunol Article American Academy of Allergy, Asthma & Immunology 2020-08 2020-05-29 /pmc/articles/PMC7256545/ /pubmed/32479759 http://dx.doi.org/10.1016/j.jaci.2020.05.021 Text en © 2020 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Liu, Jing Zheng, Xiaobin Huang, Yiying Shan, Hong Huang, Jin Successful use of methylprednisolone for treating severe COVID-19 |
title | Successful use of methylprednisolone for treating severe COVID-19 |
title_full | Successful use of methylprednisolone for treating severe COVID-19 |
title_fullStr | Successful use of methylprednisolone for treating severe COVID-19 |
title_full_unstemmed | Successful use of methylprednisolone for treating severe COVID-19 |
title_short | Successful use of methylprednisolone for treating severe COVID-19 |
title_sort | successful use of methylprednisolone for treating severe covid-19 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256545/ https://www.ncbi.nlm.nih.gov/pubmed/32479759 http://dx.doi.org/10.1016/j.jaci.2020.05.021 |
work_keys_str_mv | AT liujing successfuluseofmethylprednisolonefortreatingseverecovid19 AT zhengxiaobin successfuluseofmethylprednisolonefortreatingseverecovid19 AT huangyiying successfuluseofmethylprednisolonefortreatingseverecovid19 AT shanhong successfuluseofmethylprednisolonefortreatingseverecovid19 AT huangjin successfuluseofmethylprednisolonefortreatingseverecovid19 |